Latest market price
523.93
-11.24-2.10%
VRTXQT69Vertex Pharmaceuticals Incorporated·NASDAQ
523.93-2.10%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Oct 22, 20263Initial statement of beneficial ownership
Oct 22, 20264Statement of changes in beneficial ownership
Oct 20, 20268-KCurrent report
Oct 19, 20264Statement of changes in beneficial ownership
Oct 19, 20264Statement of changes in beneficial ownership
Sep 10, 20263Initial statement of beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20268-KCurrent report
Aug 31, 20264Statement of changes in beneficial ownership
Aug 27, 2026144Notice of proposed sale of restricted securities
Aug 04, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 23, 20264Statement of changes in beneficial ownership
Jul 23, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 07, 20268-KCurrent report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 02, 2026144Notice of proposed sale of restricted securities
Jul 02, 2026144Notice of proposed sale of restricted securities
Jul 01, 2026144Notice of proposed sale of restricted securities
Jun 30, 20264Statement of changes in beneficial ownership